RSKD insider sells 20,000 shares under 10b5-1

RSKD: Form 144 filing reporting insider sales.

Rhea-AI Filing Summary

RSKD: Form 144 filing reporting insider sales. The filing records sales by Aglika Dotcheva of Common shares via prearranged 10b5-1 plans on multiple dates: 20,000 shares on 07/01/2026, 19,600 shares on 06/01/2026, 800 shares on 07/02/2026, and 400 shares on 05/19/2026. The securities sold were linked to Restricted Stock Units originally dated 01/01/2023.

Insights

Corporate Governance Analyst

Routine insider dispositions under a 10b5-1 plan; disclosure of multiple sales.

The filing lists several dispositions by Aglika Dotcheva executed under prearranged 10b5-1 instructions on specific dates, with the largest single reported sale being 20,000 shares on 07/01/2026. The transactions are recorded as sales of Common stock tied to Restricted Stock Units dated 01/01/2023.

Cash‑flow treatment and proceeds recipients are the selling person; timing and plan terms are not detailed in the excerpt. Subsequent filings may provide plan specifics or confirm exhaustion of the planned schedule.

Key Figures

Sale on 07/01/2026: 20,000 shares Sale on 06/01/2026: 19,600 shares Sale on 07/02/2026: 800 shares +3 more

6 metrics

Sale on 07/01/2026 20,000 shares sale reported on 07/01/2026

Sale on 06/01/2026 19,600 shares sale reported on 06/01/2026

Sale on 07/02/2026 800 shares sale reported on 07/02/2026

Sale on 05/19/2026 400 shares sale reported on 05/19/2026

Original grant date Restricted Stock Units dated 01/01/2023 RSUs tied to the reported sales

Proceeds example $100,270.00 proceeds listed for 20,000-share sale on 07/01/2026

Key Terms

10b5-1, Restricted Stock Units, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 19200 | 07/01/2023"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales does the RSKD Form 144 report?

The Form 144 reports insider sales by Aglika Dotcheva of Common shares on several dates. It lists 20,000 shares on 07/01/2026, 19,600 shares on 06/01/2026, 800 shares on 07/02/2026, and 400 shares on 05/19/2026.

Were the RSKD sales executed under a trading plan?

Yes. The excerpt states the transactions were 10b5-1 Sales, indicating they were executed under prearranged trading plans. The filing lists each sale date and share count but does not include plan terms in the excerpt.

What type of securities were sold in the RSKD filing?

The securities sold are reported as Common shares linked to Restricted Stock Units dated 01/01/2023. The Form 144 ties the dispositions to those RSUs rather than open-market purchases.

Who is the reporting person in the RSKD Form 144?

The reporting person is Aglika Dotcheva, with an address listed at 220 5th Avenue, 2nd Floor, New York, NY. The filing shows multiple 10b5-1 sale entries attributed to that person.

Does the Form 144 disclose proceeds received from the sales?

The excerpt provides per-sale proceeds amounts for each entry (e.g., $100,270.00 for 20,000 shares on 07/01/2026). It lists dollar amounts next to each sale line in the table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001955807
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RISKIFIED LTD
SEC File Number	001-40692
Address of Issuer	220 5th Avenue, 2nd Floor New York NEW YORK 10001
Phone	2033009264
Name of Person for Whose Account the Securities are To Be Sold	AGLIKA DOTCHEVA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19200	98496.00	104034048	07/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2023	Restricted Stock Units	Issuer			19200	07/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	07/02/2026	800	4160.00
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	07/01/2026	20000	100270.00
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	06/01/2026	19600	98039.20
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	05/19/2026	400	2000.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 7/1/2023 through 10/1/2024.
Date of Notice	07/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Aglika Dotcheva
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)